(Q38383649)
Statements
1 reference
MISSION Trial - A phase III, multi-center, placebo-controlled trial of sorafenib in patients with relapsed or refractory predominantly non-squamous NSCLC after 2 or 3 previous treatment regimens (English)
1 reference
Luis Paz-Ares
1 reference
Vera Hirsh
1 reference
Li Zhang
1 reference
Filippo de Marinis
1 reference
James Chih-Hsin Yang
1 reference
Heather A Wakelee
1 reference
Takashi Seto
1 reference
Yi-Long Wu
1 reference
Silvia Novello
1 reference
Erszébet Juhász
1 reference
Osvaldo Arén
1 reference
Yan Sun
1 reference
Thomas Schmelter
1 reference
Teng Jin Ong
1 reference
Carol Peña
1 reference
Egbert F Smit
1 reference
Tony S Mok
1 reference
6 November 2015
1 reference
1 reference
Identifiers
1 reference